Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

A Study of Gemcitabine, Epirubicin, and Paclitaxel Combination Chemotherapy Given Before Surgery to Patients With Locally Advanced Breast Cancer

This study has been completed.
Information provided by:
NSABP Foundation Inc Identifier:
First received: September 7, 2006
Last updated: November 24, 2008
Last verified: November 2008